Innovative MedTech, Inc.

OTCPK:IMTH Stock Report

Market Cap: US$11.5m

Innovative MedTech Past Earnings Performance

Past criteria checks 0/6

Innovative MedTech's earnings have been declining at an average annual rate of -11.6%, while the Healthcare industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 23.5% per year.

Key information

-11.6%

Earnings growth rate

47.4%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate23.5%
Return on equityn/a
Net Margin-488.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Innovative MedTech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:IMTH Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242-960
30 Jun 242-850
31 Mar 242-220
31 Dec 232-210
30 Sep 232-310
30 Jun 232-410
31 Mar 232-20180
31 Dec 221-20180
30 Sep 221-19180
30 Jun 221-18180
31 Mar 221-110
31 Dec 211-310
30 Sep 211-310
30 Jun 210-310
30 Jun 200000
30 Jun 190000
31 Oct 140000
31 Jul 140000
30 Apr 140000

Quality Earnings: IMTH is currently unprofitable.

Growing Profit Margin: IMTH is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: IMTH is unprofitable, and losses have increased over the past 5 years at a rate of 11.6% per year.

Accelerating Growth: Unable to compare IMTH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: IMTH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.4%).


Return on Equity

High ROE: IMTH's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 05:03
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Innovative MedTech, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution